查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1671868

融合切片检查市场：依切片检查路径、依产品、依应用、依最终使用者、按地区

Fusion Biopsy Market, By Biopsy Route, By Product, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 157 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球融合切片检查市场规模估计为 7.911 亿美元，预计 2032 年将达到 14.182 亿美元，2025 年至 2032 年的复合年增长率为 8.7%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 7.911亿美元
效能资料 2020-2024 预测期 2025-2032
预测期：2025-2032年复合年增长率： 8.70％ 2032 年价值预测 14.182亿美元
市场占有率。
融合切片市场-IMG1

融合切片检查结合了磁振造影（MRI）和超音波两种医疗图像技术，为切片检查过程提供即时影像引导并提高准确性。这使临床医生能够识别体内的可疑组织并采集组织样本，同时最大限度地降低取样错误或漏诊病变的风险。全球前列腺癌、肺癌和乳癌病例的不断增加，推动了全球对融合切片检查等先进切片检查技术的需求。在预计预测期内，老年人口的增加、对早期癌症诊断认识的不断提高、医学影像处理系统的技术进步以及新兴市场的医疗支出不断增加等因素将推动市场成长。

市场动态：

全球融合切片检查市场受到癌症发病率上升、对微创手术的偏好增加以及对精确组织采样技术的需求增加的推动。根据世界卫生组织预测，未来20年全球癌症发生率预计将增加70%以上。融合切片检查有助于早期癌症检测，同时最大限度地减少取样误差的可能性。这就是推动其在世界各地传播的因素。然而，融合切片检查设备的高安装和维护成本抑制了市场的成长。市场进入者的机会包括扩大在新兴市场的区域影响力、推出价格实惠的设备以及提供付费经营模式。越来越多整合人工智慧、机器人和 3D成像技术的先进设备的核准和推出也可能为未来几年提供新的机会。例如，2022 年，医疗设备製造商 CMR Surgical 凭藉其用于软组织手术的 Versius 手术机器人系统获得了美国FDA 颁发的突破性设备称号。

本研究的主要特点

本研究报告对全球融合切片检查市场进行了详细分析，并提供了预测期（2025-2032）的市场规模和年复合成长率（CAGR%），假设 2024 年为基准年。

它还揭示了不同领域的潜在商机并说明了该市场的引人注目的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

全球融合切片检查市场的主要企业是根据公司亮点、产品系列、关键亮点、性能和策略等参数进行的分析。

主要企业包括通用电气医疗集团、荷兰皇家飞利浦公司、富士胶片株式会社、西门子医疗集团、日立公司、佳能医疗系统株式会社、美敦力公司、豪洛捷公司、瓦里安医疗系统、波士顿科学公司、碧迪公司、安捷伦科技公司、3M 公司、锐软医疗系统有限公司、东软医疗系统有限公司。

本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

相关人员将透过用于分析全球融合切片检查市场的各种策略矩阵来做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规与趋势分析

  • 市场动态

4. 2020 年至 2032 年按切片检查途径分類的全球融合切片检查市场

  • 经直肠
  • 经会阴

5. 2020 年至 2032 年全球融合切片检查市场（依产品划分）

  • 装置
  • 耗材

6. 2020 年至 2032 年全球融合切片检查市场（按应用）

  • 摄护腺癌
  • 其他的

7. 2020 年至 2032 年全球融合切片检查市场（按最终用户划分）

  • 医院
  • 诊断中心
  • 门诊治疗中心
  • 学术研究所
  • 其他的

8. 2020 年至 2032 年全球融合切片检查市场（按地区）

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第九章 竞争格局

  • GE Healthcare
  • Koninklijke Philips NV
  • FUJIFILM Corporation
  • Siemens Healthineers
  • Hitachi, Ltd.
  • Canon Medical Systems Corporation
  • Medtronic
  • Hologic, Inc.
  • Varian Medical Systems
  • Boston Scientific Corporation
  • Becton, Dickinson and Company
  • Agilent Technologies, Inc.
  • 3M Company
  • Carestream Health
  • Neusoft Medical Systems Co., Ltd.

第 10 章分析师建议

  • 命运之轮
  • 分析师观点
  • 一致的机会地图

第 11 章 参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI7697

The Global Fusion Biopsy Market is estimated to be valued at USD 791.1 Mn in 2025and is expected to reach USD 1,418.2 Mn by 2032 exhibiting a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 791.1 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.70% 2032 Value Projection: USD 1,418.2 Mn
Figure. Fusion Biopsy Market Share (%), By Region, 2025
Fusion Biopsy Market - IMG1

Fusion biopsy combines two medical imaging technologies, magnetic resonance imaging (MRI), and ultrasound, to provide real-time image guidance for biopsy procedures with improved accuracy. It helps physicians locate suspicious tissue in the body and obtain tissue samples with minimal risk of sampling error or missing lesions. With rising cases of prostate, lung, and breast cancer worldwide, the demand for advanced biopsy techniques like fusion biopsy is increasing globally. Factors such as growing geriatric population, increasing awareness about early cancer diagnosis, technological advancements in medical imaging systems, and rising healthcare expenditure in developing countries are expected to drive the market growth during the forecast period.

Market Dynamics:

The global fusion biopsy market is driven by the rising prevalence of cancer, increasing preference for minimally invasive surgeries, and growing need for accurate tissue sampling techniques. According to WHO, cancer burden is expected to rise by over 70% in the next 20 years worldwide. Fusion biopsy aids in detecting cancers at an early stage with minimal chances of sampling errors. This is propelling its adoption globally. However, high installation and maintenance costs of fusion biopsy devices is restraining market growth. Opportunities for market players lie in expanding their regional presence in emerging markets, launching affordable devices and offering pay-per-use business models. Increasing approvals and launch of advanced devices integrated with artificial intelligence, robotics and 3D imaging technologies will also offer new opportunities in coming years. For example, in 2022, CMR Surgical, a medical equipment manufacturer, received breakthrough device designation from the U.S. FDA for its Versius surgical robotic system for soft tissue procedures.

Key Features of the Study:

This report provides in-depth analysis of the global fusion biopsy market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global fusion biopsy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include GE Healthcare, Koninklijke Philips N.V., FUJIFILM Corporation, Siemens Healthineers, Hitachi, Ltd., Canon Medical Systems Corporation, Medtronic, Hologic, Inc., Varian Medical Systems, Boston Scientific Corporation, Becton, Dickinson and Company, Agilent Technologies, Inc., 3M Company, Carestream Health, and Neusoft Medical Systems Co., Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global fusion biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fusion biopsy market

Market Segmentation

  • Biopsy Route Insights (Revenue, USD Mn, 2020 - 2032)
    • Transrectal
    • Transperineal
  • Product Insights (Revenue, USD Mn, 2020 - 2032)
    • Equipment
    • MRI machines
    • Ultrasound devices
    • Fusion biopsy systems
    • Others
    • Consumables
    • Biopsy needles
    • Imaging contrast agents
    • Others
  • Application Insights (Revenue, USD Mn, 2020 - 2032)
    • Prostate Cancer
    • Others
  • End User Insights (Revenue, USD Mn, 2020 - 2032)
    • Hospitals
    • Diagnostic Centers
    • Ambulatory Care Centers
    • Academic & Research Laboratories
    • Others
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • GE Healthcare
    • Koninklijke Philips N.V.
    • FUJIFILM Corporation
    • Siemens Healthineers
    • Hitachi, Ltd.
    • Canon Medical Systems Corporation
    • Medtronic
    • Hologic, Inc.
    • Varian Medical Systems
    • Boston Scientific Corporation
    • Becton, Dickinson and Company
    • Agilent Technologies, Inc.
    • 3M Company
    • Carestream Health
    • Neusoft Medical Systems Co., Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Fusion Biopsy Market, By Biopsy Route
    • Global Fusion Biopsy Market, By Product
    • Global Fusion Biopsy Market, By Application
    • Global Fusion Biopsy Market, By End User
    • Global Fusion Biopsy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER's Analysis
    • Merger and Acquisition Scenario
    • Industry Trends

4. Global Fusion Biopsy Market, By Biopsy Route, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Transrectal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Transperineal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Fusion Biopsy Market, By Product, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • MRI machines
    • Ultrasound devices
    • Fusion biopsy systems
    • Others
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Biopsy needles
    • Imaging contrast agents
    • Others

6. Global Fusion Biopsy Market, By Application, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Prostate Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Fusion Biopsy Market, By End User, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Ambulatory Care Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Academic & Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Fusion Biopsy Market, By Region, 2020 - 2032, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Biopsy Route, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Koninklijke Philips N.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • FUJIFILM Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hitachi, Ltd.
  • Canon Medical Systems Corporation
  • Medtronic
  • Hologic, Inc.
  • Varian Medical Systems
  • Boston Scientific Corporation
  • Becton, Dickinson and Company
  • Agilent Technologies, Inc.
  • 3M Company
  • Carestream Health
  • Neusoft Medical Systems Co., Ltd.

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us